v3.24.3
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Collaboration revenue $ 30,017 $ 3,318 $ 48,167 $ 8,152
Operating expenses:        
Research and development 42,212 30,878 121,251 98,758
General and administrative 10,562 10,172 32,195 31,670
Total operating expenses 52,774 41,050 153,446 130,428
Loss from operations (22,757) (37,732) (105,279) (122,276)
Other (expense) income, net:        
Interest income 5,324 4,854 14,531 13,993
Non-cash interest expense for the sale of future royalties (15,413) (4,431) (32,683) (13,125)
Other (expense) income, net (5) 1 (7) 0
Total other (expense) income, net (10,094) 424 (18,159) 868
Loss before income taxes (32,851) (37,308) (123,438) (121,408)
Provision for income taxes 0 0 (9) 0
Net loss (32,851) (37,308) (123,447) (121,408)
Unrealized gain on available for sale securities 1,174 1,261 1,556 2,896
Comprehensive loss $ (31,677) $ (36,047) $ (121,891) $ (118,512)
Net loss per common share:        
Basic (in dollars per share) $ (1.14) $ (1.41) $ (4.46) $ (4.49)
Diluted (in dollars per share) $ (1.14) $ (1.41) $ (4.46) $ (4.49)
Weighted-average number of shares outstanding:        
Basic (in shares) 28,893 26,546 27,688 27,038
Diluted (in shares) 28,893 26,546 27,688 27,038